Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib

Clin Lymphoma Myeloma Leuk. 2024 Feb 29:S2152-2650(24)00092-2. doi: 10.1016/j.clml.2024.02.014. Online ahead of print.NO ABSTRACTPMID:38503634 | DOI:10.1016/j.clml.2024.02.014

Source: Clinical Lymphoma and Myeloma - March 19, 2024 Category: Cancer & Oncology Authors: Fadi G Haddad Cedric Nasnas Koji Sasaki Shilpa Paul Ghayas C Issa Caitlin Rausch Elias Jabbour Hagop Kantarjian Source Type: research